1. Medtech Insight
  2. >>Device Area
  3. >>Diagnostics
  4. >>In Vitro Diagnostics

HiberGene's Rapid Group B Strep Test Pregnant With Potential

 
• By Tina Tan

A year after launching its first product, rapid molecular diagnostics specialist HiberGene now has a trio of infectious diseases tests under its belt. One of the tests, designed to detect Group B Streptococcus in pregnant women, is expected to be a major cash generator for the firm once it begins its sales ramp-up.

Pregnant belly
Hibergene launches rapid Group B Strepococcus test • Source: shutterstock.com

Many may not have heard of Group B Streptococcus, but emerging Irish in vitro diagnostics company HiberGene Diagnostics Ltd. believes the life-threatening consequences of infections caused by this bacterium have carved out a potentially lucrative market. The firm launched its HG GBS rapid test at the end of last year to try to take advantage of the opportunity.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from In Vitro Diagnostics

More from Diagnostics